Investigating the next frontier of precision cancer treatments
Strata PATH is a prospective pan-tumor therapeutic trial designed to evaluate the efficacy and safety of multiple FDA-approved cancer therapies in new, biomarker-guided patient populations. This multi-arm study includes cohorts for antibody-drug conjugates, immunotherapy and angiogenesis inhibitors.
Understanding the impact of precision oncology
Strata Trial is a non-randomized, large-scale observational trial evaluating the clinical benefit of systematic comprehensive genomic profiling and quantitative RNA expression profiling for participants with advanced cancer using real-world data and endpoints.
There is no time to spare when it comes to getting patients their best possible treatment
We are delivering on the promise of precision oncology, empowering our health system partners to provide the right drug to the right patient at the right time.
If you’re a patient, find out how precision oncology treatment may impact your care.